Rivvit appoints Bret Bange as Chief Revenue and Strategy Officer
Investment data management platform welcomes seasoned fintech leader to drive growth amid rapid product innovation CHICAGO, Jan. 7, 2026 /PRNewswire/ — Rivvit,... Read more.
The Blackhawk Group Welcomes Silver Sky Aviation, Expanding Performance Center Network into Alaska with Sixth Location
PHOENIX, Jan. 7, 2026 /PRNewswire/ — The Blackhawk Group (“TBG”), a leader in turboprop performance solutions, including engine, propeller, and... Read more.
KITS Eyecare Reports Preliminary Fourth Quarter and Full Year 2025 Results
Q4 Revenue Increased 20% Year-Over-Year to Approximately $53.9 Million Record Q4 Glasses Revenue Accelerated to $8.7M, Growing Approximately 33% Year-Over-Year Full... Read more.
Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026
NEW HAVEN, Conn., Jan. 7, 2026 /PRNewswire/ — Biohaven Ltd. (NYSE: BHVN) today announced that Vlad Coric, M.D., Chairman and Chief Executive Officer, will... Read more.
Genprex Provides Clinical Update on Diabetes Gene Therapy Program
Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ — Genprex,... Read more.
Criteo Provides Update on Luxembourg Redomiciliation
Shareholder Meeting to be Convened on February 27, 2026 NEW YORK, Jan. 7, 2026 /PRNewswire/ — Criteo S.A. (NASDAQ: CRTO) (“Criteo” or the “Company“),... Read more.
WARNER BROS. DISCOVERY BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT AMENDED PARAMOUNT TENDER OFFER
Offer Remains Inferior to Netflix Merger Agreement Across Numerous Key Areas Value is Insufficient Given Significant Costs, Risks and Uncertainties Heightened Risk... Read more.
RTX Recommends Shareholders Reject “Mini-Tender” Offer by Tutanota LLC
ARLINGTON, Va., Jan. 7, 2026 /PRNewswire/ — RTX (NYSE: RTX) has received notice of an unsolicited “mini-tender” offer made by Tutanota LLC (Tutanota)... Read more.
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design... Read more.
Ping Identity Marks Digital Trust Milestone with Zero-Knowledge Biometrics in the Age of AI
Completion of the Keyless acquisition adds privacy-preserving biometric authentication andre-verification to strengthen enterprise defenses against AI-powered spoofing... Read more.